From Stephen to Zithromax
A fascinating story in The Harvard Crimson details a rather shocking security lapse in which “the confidential drug purchase histories of many Harvard students and employees have been available for months to any internet user, as have the e-mail addresses of high-profile undergraduates whose contact information the University legally must conceal,” according to the magazine.
The problem seems to be that two Harvard websites designed for student use did not properly authenticate the students who were supposed to be using them.
One website, now disabled, is the iCommons Poll Tool. According to the Crimson, that website “required nothing more than a free, anonymous Hotmail account and five minutes to look up the eight-digit ID of any student, faculty or staff member.” With that number, anybody could then go to the website operated by Harvard’s insurer’s website, PharmaCare, type in the Harvard University ID and the student’s date of birth (obtainable from the student directory and from “sites such as anybirthday.com,” and get the full history of all drugs that the student had ordered
There is a related issue involving the listing of student directory information if when students request that this information not be made available, a violation of another federal law.
Hats off to the Crimson! They also broke a story similar to this roughly 10 years ago, when it was revealed that Usenet browsing history was being left on public-access terminals.
Keep Reading
Most Popular

The hype around DeepMind’s new AI model misses what’s actually cool about it
Some worry that the chatter about these tools is doing the whole field a disservice.

These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.

Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.

A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Stay connected

Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.